CJC-1295 with DAC and Sermorelin Interaction
CJC-1295 with DAC and Sermorelin have an interaction requiring monitoring for interaction with 90% confidence. CJC-1295 DAC is already more potent and long-lasting. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.
Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
View full profileSermorelin
GHRH Analog | Growth Hormone Releasing Hormone
Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 with DAC with Sermorelin?
Yes, but with caution. CJC-1295 DAC is already more potent and long-lasting. Regular monitoring is advised.
Is CJC-1295 with DAC and Sermorelin safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.
What are the interactions between CJC-1295 with DAC and Sermorelin?
CJC-1295 DAC is already more potent and long-lasting. This assessment has 90% confidence and is based on documented research data.
How should I time CJC-1295 with DAC and Sermorelin?
CJC-1295 with DAC has a half-life of 6-8 days and Sermorelin has a half-life of 10-12 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.